MTOR and colorectal carcinoma: Taken together, our results demonstrated that elevated expression of α3 in the CRC of mice or patients promoted metastasis via downregulation of p53-PTEN/IGFBP3 and subsequent activation of mTOR, and bufalin inhibited this action (Figure 6F).